ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $667,621 | +9.4% | 26,130 | +22.8% | 0.28% | +2.6% |
| Q2 2023 | $610,138 | -20.9% | 21,274 | -33.9% | 0.27% | -26.7% |
| Q1 2023 | $771,091 | +117.8% | 32,169 | +43.0% | 0.37% | +42.1% |
| Q2 2022 | $354,000 | +40.5% | 22,499 | +326.1% | 0.26% | +31.2% |
| Q3 2021 | $252,000 | +16.1% | 5,280 | -17.7% | 0.20% | +26.8% |
| Q2 2021 | $217,000 | -50.7% | 6,417 | -37.4% | 0.16% | -52.1% |
| Q3 2020 | $440,000 | -17.9% | 10,248 | -10.7% | 0.33% | -20.2% |
| Q2 2020 | $536,000 | -22.7% | 11,478 | -77.5% | 0.41% | -51.1% |
| Q1 2020 | $693,000 | +22.7% | 51,021 | -1.8% | 0.84% | +103.4% |
| Q4 2019 | $565,000 | +43.0% | 51,982 | +35.2% | 0.41% | +26.7% |
| Q3 2019 | $395,000 | +9.4% | 38,461 | +0.7% | 0.33% | +42.4% |
| Q2 2019 | $361,000 | – | 38,207 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |